Medtronic, Bayer Healthcare extend diabetes alliance

Medtronic and Bayer HealthCare have expanded their alliance to include the U.S. The companies will work exclusively to develop next generation diabetes management solutions for patients.

The companies have collaborated for more than three years by providing Bayer's CONTOUR Link meter to diabetics who use compatible MiniMed Paradigm insulin pumps and the Guardian REAL-Time continuous glucose monitoring system from Medtronic.

"Our goal is to improve patient outcomes while delivering an exceptional customer experience," said Katie Szyman, president of the Diabetes business and senior vice president at Medtronic. "We are excited to work with Bayer to develop and deliver future integrated solutions that are even smaller and easier to use, with accuracy that surpasses today's standards in diabetes management."

- see the joint Medtronic-Bayer release

ALSO: LifeScan has fulfilled the terms of its exclusive three-year agreement to provide Medtronic customers in the U.S. with the OneTouch UltraLink blood glucose meter that wirelessly transmits glucose values to Medtronic MiniMed Paradigm insulin pumps and Guardian REAL-Time continuous glucose monitoring systems. LifeScan release

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.